EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PFKP promotes oncogenesis in osteosarcoma through PI3K/HIF-1α pathway-mediated H3K18la modification

Xue Zhang, Mingyue Guan, Yuanyuan Wang, Chenglong Ding, Xingchen Yu, Jiale Shi, Jingwen He, Shuang Liu, Qi Liu

Cellular Signalling · 2026-11 · 147 · 112733

DOI: 10.1016/j.cellsig.2026.112733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026-11. Verfasst von Xue Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical, Jiamusi University, Jiamusi, Heilongjiang 154007, China. Hauptthemen laut MEDLINE: Osteosarcoma, Hypoxia-Inducible Factor 1, alpha Subunit, Phosphatidylinositol 3-Kinases, Histones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heilongjiang Province Natural Science Foundation, Jiamusi University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The preferential utilization of aerobic glycolysis by cancer cells causes lactate accumulation, resulting in histone H3 lysine 18 lactylation (H3K18la), lactylation of other proteins, and alterations in gene expression. Given the rate-limiting actions of phosphofructokinase-platelet (PFKP) in glycolysis, its upregulation occurs in various cancer types; however, PFKP's role in osteosarcoma remains unclear. Here, we report that PFKP may promote osteosarcoma progression. Initial screening of three osteosarcoma GEO datasets identified PFKP as a major differentially expressed gene (DEG). Its upregulations in tumor over normal tissues and osteosarcoma cells compared to osteoblasts were demonstrated using TNMplot database, RT-qPCR, Western blot, and immunohistochemistry (IHC). Functionally, the knockdown of PFKP in osteosarcoma 143B and MG63 cells inhibited cell proliferation and migration, accompanied by reductions in lactate production, pan-lactylation, and H3K18la both in vitro and in vivo. Mechanistically, the enrichment of the PI3K/HIF-1α pathway was observed in PFKP-related pathways; inhibition of PI3K by LY294002 downregulated PFKP expression, phosphofructokinase activity, lactate production, pan-lactylation, and H3K18la in both 143B and MG63 cells; LY294002 abolished the exogenous lactate-induced upregulation of PFKP, as well as the PFKP-dependent increases in H3K18la, PI3K, and HIF-1α. Simultaneously, the reduction of PFKP and H3K18la mediated by 2DG significantly suppressed the protein expression of PI3K and HIF-1α. ChIP-qPCR revealed a significant enrichment of H3K18la at the promoters of PIK3CA and HIF1A. Furthermore, through analysis of the HERB and CTD databases and molecular docking simulations, we uncovered the binding of a small molecule compound quercetin to PFKP with the binding energy of -8.3 kcal/mol, indicating a stable interaction. The binding was confirmed by the Cellular Thermal Shift Assay (CETSA). Of importance, quercetin decreases PFKP expression, lactate levels, pan-lactylation, and H3K18la along with inhibition of cell proliferation and migration in 143B and MG63 cells. Collectively, we provide evidence supporting that PFKP promotes osteosarcoma cell proliferation and migration via facilitating lactate production, protein lactylation, and H3K18la via processes involving PI3K/HIF-1α. This study reveals that quercetin binds PFKP with high affinity and suppresses its oncogenic actions, highlighting the therapeutic potential of targeting PFKP and utilization of quercetin in osteosarcoma management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaHypoxia-Inducible Factor 1, alpha SubunitPhosphatidylinositol 3-KinasesHistonesPhosphofructokinase-1, Type CCarcinogenesisBone NeoplasmsHumansCell Line, TumorAnimalsCell ProliferationSignal TransductionMice, NudeCell MovementMiceGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

H3K18laLactylationOsteosarcomaPFKPPI3K/HIF-1αQuercetin

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitPhosphatidylinositol 3-KinasesHistonesPFKP protein, humanPhosphofructokinase-1, Type CHIF1A protein, human

Autor:innen und Institutionen

  • Department of Basic Medical, Jiamusi University, Jiamusi, Heilongjiang 154007, China.
  • Sepsis Translational Medicine Key Laboratory of Hunan Province, Central South University, Changsha, Hunan 410078, China.
  • Department of Basic Medical, Jiamusi University, Jiamusi, Heilongjiang 154007, China. Electronic address: lius@jmsu.edu.cn.
  • Department of Oncology, The Eighth People's Hospital of Shanghai, Shanghai 200235, China. Electronic address: liuqiqi36@163.com.

Förderung

  • Heilongjiang Province Natural Science Foundation
  • Jiamusi University

Zitieren

APA

Zhang, X., Guan, M., Wang, Y., Ding, C., Yu, X., Shi, J., He, J., Liu, S., & Liu, Q. (2026). PFKP promotes oncogenesis in osteosarcoma through PI3K/HIF-1α pathway-mediated H3K18la modification. Cellular Signalling, 147, 112733. https://doi.org/10.1016/j.cellsig.2026.112733

Vancouver

Zhang X, Guan M, Wang Y, Ding C, Yu X, Shi J, et al. PFKP promotes oncogenesis in osteosarcoma through PI3K/HIF-1α pathway-mediated H3K18la modification. Cellular Signalling. 2026;147:112733. doi:10.1016/j.cellsig.2026.112733

BibTeX
@article{Zhang2026,
  author = {Zhang, Xue and Guan, Mingyue and Wang, Yuanyuan and Ding, Chenglong and Yu, Xingchen and Shi, Jiale and He, Jingwen and Liu, Shuang and Liu, Qi},
  title = {PFKP promotes oncogenesis in osteosarcoma through PI3K/HIF-1α pathway-mediated H3K18la modification},
  journal = {Cellular Signalling},
  year = {2026},
  volume = {147},
  pages = {112733},
  doi = {10.1016/j.cellsig.2026.112733}
}
Kostenlos starten →